PlexusDx vs Levity — 2026 Verified Pricing, Plans, and Fees Compared

Last reviewed: September 5, 2026 Last updated: September 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Levity provides FDA-approved branded medications—Ozempic, Mounjaro, and Wegovy—at $1,199–$1,599 per month. PlexusDx delivers compounded semaglutide and tirzepatide from licensed 503A pharmacies at $189–$289 per month. Over twelve months, Levity's Ozempic costs $14,338 versus PlexusDx compounded semaglutide injection at $2,268—a difference of $12,070. The core trade-off: FDA-approved branded drugs with established clinical trial data versus compounded formulations at a fraction of the cost. Neither option guarantees eligibility, dose progression, or weight outcomes; a licensed clinician determines appropriateness in both cases.

At-a-glance comparison: Levity vs PlexusDx

Levity's advertised first-month prices require a promotional code and are $50 lower than ongoing rates; standard monthly rates shown here. All 12-month figures are our calculations.

How Levity pricing works

Levity delivers FDA-approved branded medications billed every approximately four weeks. At checkout (verified September 4, 2026), three branded options appeared with distinct pricing:

• Ozempic (branded semaglutide injection, FDA-approved for type 2 diabetes): advertised first-month rate of $1,149 with a promotional code, then $1,199 per month ongoing.
• Mounjaro (branded tirzepatide injection, FDA-approved for type 2 diabetes): advertised first-month rate of $1,249 with a promotional code, then $1,299 per month ongoing.
• Wegovy (branded semaglutide injection, FDA-approved specifically for weight management): advertised first-month rate of $1,549 with a promotional code, then $1,599 per month ongoing.

The promotional code reduces the first month by $50 across all three drugs. After month one, the standard rate applies for every subsequent billing cycle. Levity also offers compounded liraglutide, though pricing for that formulation was not captured in this verification.

Each Levity price is all-inclusive: medication, consultation, care coordination, and shipping bundled into one figure. There is no separate membership fee or per-visit charge. Patients may cancel at any time; recurring billing continues until cancellation.

How PlexusDx pricing works

PlexusDx works with licensed 503A compounding pharmacies to provide compounded semaglutide and tirzepatide in both injected and oral forms, plus a microdose GLP-1 protocol. Month-to-month rates for injected formulations (verified September 5, 2026):

• Compounded semaglutide injection: $189 per month.
• Compounded tirzepatide injection: $289 per month.

Prepaid plans lower the effective monthly rate: semaglutide injection falls to $169 per month over three months (prepaid) or $149 per month over six months (prepaid); tirzepatide injection falls to $269 per month over three months or $249 per month over six months. These are our calculations of the per-month equivalent; the patient prepays the full cycle cost upfront.

PlexusDx also offers oral capsule formulations—compounded semaglutide oral at $289 per month and compounded tirzepatide oral at $349 per month—and a microdose GLP-1 injection at $129 per month. Every PlexusDx price includes the medication, provider visit, prescription, and shipping; there is no membership fee. The advertised rate equals the ongoing rate—no separate introductory pricing. Same flat price at every dose level.

Normalized 12-month cost: semaglutide

To compare Levity's branded Ozempic with PlexusDx's compounded semaglutide injection on equal footing, we calculate total cost over twelve months and derive the effective monthly rate. All figures below are our calculations unless otherwise noted.

Levity Ozempic (branded semaglutide injection):

• Month 1: $1,149 (advertised first-month rate with promotional code, captured September 4, 2026).
• Months 2–12: $1,199 × 11 = $13,189.
• 12-month total: $1,149 + $13,189 = $14,338.
• Effective monthly: $14,338 ÷ 12 = $1,194.83.

PlexusDx compounded semaglutide injection (month-to-month):

• 12 months × $189 = $2,268 total.
• Effective monthly: $189.

PlexusDx compounded semaglutide injection (6-month prepaid plan):

• Two 6-month cycles at $149 per month (prepaid, our calculation): $894 per cycle.
• 12-month total: $894 × 2 = $1,788.
• Effective monthly: $149 (prepaid).

Cost difference: Levity's Ozempic costs $12,070 more than PlexusDx compounded semaglutide (month-to-month) over twelve months—approximately 6.3 times higher. Even against PlexusDx's prepaid six-month plan, Levity costs $12,550 more over the same period.

Normalized 12-month cost: tirzepatide

Levity Mounjaro (branded tirzepatide injection):

• Month 1: $1,249 (advertised first-month rate with promotional code, captured September 4, 2026).
• Months 2–12: $1,299 × 11 = $14,289.
• 12-month total: $1,249 + $14,289 = $15,538.
• Effective monthly: $15,538 ÷ 12 = $1,294.83.

PlexusDx compounded tirzepatide injection (month-to-month):

• 12 months × $289 = $3,468 total.
• Effective monthly: $289.

PlexusDx compounded tirzepatide injection (6-month prepaid plan):

• Two 6-month cycles at $249 per month (prepaid, our calculation): $1,494 per cycle.
• 12-month total: $1,494 × 2 = $2,988.
• Effective monthly: $249 (prepaid).

Cost difference: Levity's Mounjaro costs $12,070 more than PlexusDx compounded tirzepatide (month-to-month) over twelve months—approximately 4.5 times higher. Against the prepaid plan, Levity costs $12,550 more.

The brand-name advantage: FDA approval and clinical trial data

Levity's core strength is straightforward: every medication it dispenses—Ozempic, Mounjaro, Wegovy—is FDA-approved. That approval rests on Phase III randomized controlled trials involving thousands of participants, with documented efficacy and safety profiles published in peer-reviewed journals. Ozempic and Mounjaro carry FDA approval for type 2 diabetes; Wegovy is approved specifically for chronic weight management. When a patient receives branded Ozempic or Mounjaro, the formulation, dosing pen, and active pharmaceutical ingredient match exactly what was tested in those trials.

Compounded medications—the category PlexusDx operates within—do not undergo FDA review for safety, effectiveness, or quality before reaching patients. A licensed compounding pharmacy prepares each prescription individually under state board of pharmacy oversight and USP <795> or <797> standards, but the finished product has not passed through the FDA's New Drug Application process. For patients who prioritize regulatory review or whose insurance may cover branded drugs, Levity's approach delivers that assurance.

Levity bundles all services—consultation, care coordination, medication, and shipping—into one recurring price. Patients interact with licensed clinicians, receive the branded medication directly, and cancel at any time without penalty. The process is logistically similar to PlexusDx or other telehealth platforms, but the drug dispensed is materially different in regulatory status.

The compounded advantage: cost and flexibility

PlexusDx holds a cost advantage that is difficult to overstate. At $189 per month for compounded semaglutide injection and $289 per month for compounded tirzepatide injection, a patient on PlexusDx spends $2,268 or $3,468 respectively over twelve months. Levity's equivalent branded drugs cost $14,338 (Ozempic) and $15,538 (Mounjaro) over the same period—differences of $12,070 and $12,070. For patients paying out-of-pocket and facing multi-year treatment timelines, that gap is often decisive.

PlexusDx works with licensed 503A compounding pharmacies that prepare semaglutide and tirzepatide under sterile or non-sterile conditions (depending on route) according to USP standards. Each prescription is individualized; a licensed clinician evaluates the patient's history, determines appropriateness, and prescribes the specific compound, strength, and route. PlexusDx offers both injected and oral formulations, giving patients who prefer to avoid needles a capsule alternative (compounded semaglutide oral at $289 per month, compounded tirzepatide oral at $349 per month). The microdose GLP-1 protocol at $129 per month provides a lower-intensity maintenance option for patients not pursuing maximum weight reduction.

Every PlexusDx price is flat across dose levels—the same monthly charge whether the clinician prescribes 0.25 mg, 0.5 mg, 1.0 mg, or higher. There is no membership fee, no separate consultation charge, and no introductory-versus-refill pricing structure. The advertised rate is the ongoing rate. Patients on month-to-month plans may cancel anytime; those who prepay for three- or six-month cycles pay upfront and receive a lower effective monthly rate, but those plans are non-refundable.

PlexusDx holds a 4.2-star rating on Trustpilot, with 76 percent of reviews at five stars and 81 percent at four stars or higher (captured September 4, 2026). That record suggests consistent fulfillment and support, though individual experiences vary.

Decision factors: insurance, regulatory preference, and budget

Insurance coverage is the first variable to check. If a patient's plan covers Ozempic, Mounjaro, or Wegovy with a reasonable copay, Levity's role becomes facilitating access to that coverage. Some insurers will reimburse telehealth-dispensed branded drugs; others require in-network pharmacies. Levity's billing team can clarify reimbursement pathways, but patients should verify coverage independently before committing. If insurance reduces the net branded-drug cost below $200–$300 per month, the price advantage of compounded alternatives narrows or disappears.

For patients paying entirely out-of-pocket, the arithmetic is stark. Levity costs roughly five to six times more than PlexusDx over twelve months. That premium buys FDA approval, brand-name assurance, and the exact formulation tested in pivotal trials. Some patients value that regulatory backing enough to justify the expense; others prioritize affordability and accept that compounded drugs do not carry the same review standard.

Formulation preference matters. Levity dispenses pre-filled branded pens (Ozempic, Mounjaro, Wegovy) designed for subcutaneous injection. PlexusDx offers both injected and oral routes; patients who strongly prefer to avoid injections can choose compounded oral capsules (semaglutide or tirzepatide) at $289–$349 per month. Levity does not currently offer an oral GLP-1 option for semaglutide or tirzepatide, though it does provide compounded liraglutide (pricing not captured in this verification).

Cancellation and commitment terms are similar: both platforms allow month-to-month cancellation. Levity bills every four weeks on a recurring basis until the patient cancels; PlexusDx month-to-month plans work the same way. PlexusDx's prepaid multi-month options lock in a lower rate but require upfront payment and are non-refundable.

Choose Levity if…

• You have insurance coverage or reimbursement for branded Ozempic, Mounjaro, or Wegovy, and Levity can facilitate that billing.
• You strongly prefer FDA-approved branded medications with published Phase III trial data, and the regulatory distinction justifies the price premium.
• You want Wegovy specifically—the only semaglutide formulation FDA-approved explicitly for chronic weight management—and are willing to pay $1,599 per month ongoing for that label.
• You value a single all-inclusive branded-drug service with bundled consultation, medication, and shipping, and cost is not the primary constraint.

Choose PlexusDx if…

• You are paying out-of-pocket and prioritize the lowest sustainable monthly cost—$189 for compounded semaglutide injection or $289 for compounded tirzepatide injection—over branded-drug status.
• You want the flexibility of both injected and oral GLP-1 formulations, or you prefer to avoid needles entirely and will accept compounded oral capsules at $289–$349 per month.
• You are comfortable with compounded medications prepared by licensed 503A pharmacies under USP standards, understanding that these drugs are not FDA-approved and do not carry the same regulatory review as branded products.
• You want transparent, flat-rate pricing with no dose-based upcharges and no introductory-versus-refill pricing structure.
• You value a documented service record: PlexusDx holds a 4.2-star Trustpilot rating with 81 percent of reviews at four stars or higher.

What we still don't know

This comparison rests on checkout-verified pricing captured September 4–5, 2026. Levity's promotional code structure, standard rates, and medication lineup may change; patients should confirm current pricing at intake. We did not capture pricing for Levity's compounded liraglutide, so that option remains outside this analysis. We also did not test Levity's insurance billing or reimbursement process; patients relying on coverage should verify claim submission and approval independently.

Neither Levity nor PlexusDx guarantees eligibility, specific medication, dose escalation timeline, or weight-loss outcomes. A licensed clinician at each platform reviews the patient's medical history and determines whether a prescription is appropriate. Neither platform's evidence base includes head-to-head efficacy data comparing branded drugs to compounded formulations, so patients cannot assume equivalent results.

PlexusDx's Trustpilot rating was verified September 4, 2026; Levity's review record on Trustpilot or other platforms was not captured in this research cycle. Both platforms' cancellation policies are documented (cancel anytime), but we do not have evidence on refund processing time, prescription transfer procedures, or customer-service response intervals.

Methodology and freshness

Levity pricing and medication details were verified through a completed intake and checkout process on September 4, 2026, at 13:49:55 UTC; no payment was submitted. PlexusDx pricing and service terms were captured from live product pages and the published price sheet on September 5, 2026. PlexusDx's Trustpilot rating (4.2 stars, 76 percent five-star, 81 percent four-star or higher) was verified September 4, 2026.

All 12-month cost totals and effective monthly rates are our calculations unless explicitly attributed to a source. Levity's advertised first-month promotional prices appear in this article only in the body, labeled as "advertised first-month rate" or "with promotional code," and are always paired with the standard ongoing rate. We do not publish promotional codes themselves.

Compounded-medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Frequently Asked Questions

Is Levity's Ozempic the same formulation as what an endocrinologist would prescribe?

Yes. Levity dispenses branded Ozempic manufactured by Novo Nordisk, the same FDA-approved product available through traditional prescriptions and pharmacies. The pen device, active ingredient concentration, and dosing increments match exactly what appears in pivotal clinical trials and the FDA label.

Are PlexusDx's compounded semaglutide and tirzepatide as effective as branded drugs?

Compounded medications are not FDA-approved and have not undergone the Phase III randomized controlled trials required for branded drugs. While they use the same active pharmaceutical ingredients (semaglutide or tirzepatide), potency, sterility, and consistency are governed by state pharmacy boards and USP standards, not FDA New Drug Application review. A licensed clinician determines appropriateness, but no head-to-head efficacy data exists comparing compounded to branded formulations in the same patient population.

Can I use insurance to cover Levity's medications?

Levity's billing team can assist with insurance claims for branded Ozempic, Mounjaro, or Wegovy, but coverage depends entirely on your specific plan, its pharmacy network requirements, and prior-authorization policies. Some insurers reimburse telehealth-dispensed branded drugs; others do not. You should verify coverage independently and confirm whether Levity's dispensing pharmacy is in-network before assuming reimbursement.

Does PlexusDx offer branded Ozempic or Mounjaro?

No. PlexusDx works exclusively with licensed 503A compounding pharmacies to provide compounded semaglutide and compounded tirzepatide in injected and oral forms. It does not dispense FDA-approved branded drugs. Patients who require or prefer branded medications for insurance, regulatory, or personal reasons should choose a provider like Levity that offers those formulations.

How much does Wegovy cost through Levity over a full year?

Levity's Wegovy is advertised at an introductory rate of $1,549 for the first month with a promotional code, then $1,599 per month ongoing (captured September 4, 2026). Over twelve months, the total cost is $1,549 + (11 × $1,599) = $19,138, or an effective monthly rate of $1,594.83. That figure is our calculation and includes medication, consultation, care, and shipping bundled into one price.

Sources

• PlexusDx product pages and pricing (semaglutide injection, tirzepatide injection, oral formulations, microdose GLP-1), accessed September 5, 2026
• Levity medication offerings, pricing, and service terms verified through completed intake and checkout, September 4, 2026, 13:49:55 UTC
• Levity promotional code structure and first-month versus ongoing rates, captured at checkout September 4, 2026
• PlexusDx Trustpilot rating (4.2 stars, 76% five-star, 81% four-star or higher), verified September 4, 2026
• FDA regulatory framework for compounded medications versus approved drugs, standing reference

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.